Citrate salts of N-(4-{4-amino-7-[l -(2-hydroxyethyl)-lH-pyrazol-4-yl]thieno[3,2-c]pyridin-3-yl}phenyl)-N"-(3-fluorophenyl) urea and crystalline forms thereof are suitable pharmaceutical ingredients for pharmaceutical compositions useful in the treatment of disease, for example, cancer.